We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This series brings together all documents relating to drugs licensing.
Sajid Javid announces review of the scheduling of cannabis
Details of CBD product seized at a Stanford-Le-Hope depot.
Formula Swiss CBD oil for cats seized at Stanford-Le-Hope.
Healthcare professionals should be vigilant for suspected adverse reactions and safety concerns associated with e-cigarettes and e-liquids, commonly known as vapes. Please report adverse reactions to the Yellow Card scheme and promote vigilance among patients.
SIA response to a Freedom of Information (FOI) request for confirmation of whether SIA licence-linked training covers the possession of medical cannabis.
Cannabis-based products for medicinal use will be available for specialist doctors to prescribe legally.
Specialist clinicians will be able to legally prescribe cannabis-derived medicinal products by the autumn, Home Secretary Sajid Javid announced today.
Professor Sir Chris Whitty writes for The Times that marketing vapes to children is unacceptable - they should only have a role in helping smokers quit.
The ACMD has recommended that cannabis-derived medicinal products should be placed in Schedule 2 of the Misuse of Drugs Regulations 2001.
Patients prescribed cannabis-based medicines will be able to get their treatment in days rather than months.
A letter to clinicians from the Chief Medical Officer and NHS England following the rescheduling of legislation to allow the medicinal use of cannabis-based products.
Personal license applications received and granted for the importation of medicinal cannabis from October 2012 to October 2013.
The Medicines and Healthcare products Regulatory Agency has issued an opinion on the regulatory status of products containing CBD
Home Secretary to receive advice on cannabis-related medicinal products.
The Home Secretary today announced a review into the scheduling of cannabis for medicinal purposes.
The importer and distributor of the above products has informed us of reports that the microbial limit for Total Microbial Aerobic Count (TAMC) has been tested to exceed the predefined limit of 200 CfU/g as per the product specification fixed...
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).